Financial Advocates Investment Management Edwards Lifesciences Corp Transaction History

Financial Advocates Investment Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $204,313 - $302,973	2,362 New	2,362 $225,000
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $319,746 - $402,474	-3,136 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $139,344 - $171,190	1,310 Added 71.74%	3,136 $406,000
Q3 2021 Nov 04, 2021	BUY	$102.91 - $122.75 $173,197 - $206,588	1,683 Added 1176.92%	1,826 $206,000
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $2.43 Million - $2.98 Million	-52,415 Reduced 99.73%	143 $7,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $2.4 Million - $3.05 Million	52,558 New	52,558 $0

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.